General - Press Releases

Date	Title	Company
19-Dec-2023	MBrace Therapeutics Announces Initiation of Patient Dosing in Phase 1 Clinical Trial Evaluating Investigational Antibody-Drug Conjugate MBRC-101	Businesswire
19-Dec-2023	Evaxion Biotech Announces Private Placement Financing	Evaxion Biotech A/S
19-Dec-2023	Boston Pharmaceuticals Appoints Juan Carlos Lopez-Talavera, MD, PhD, as Acting Chief Medical Officer as MASH Asset BOS-580 Accelerates in Phase 2 Clinical Program	Businesswire
19-Dec-2023	Lassen Therapeutics Announces Closing of Oversubscribed $85 Million Series B Financing and Announces First Patient Dosed in the Phase 1 Trial Evaluating LASN01 in Thyroid Eye Disease	Businesswire
19-Dec-2023	Infinimmune Announces Partnership with Grid Therapeutics to Conduct Deep Sequencing of B Cells for Oncology Drug Discovery	Businesswire
19-Dec-2023	Tevogen Bio Expands Presence in Rapidly Emerging Field of Biotechnology AI: Files Patent Applications Related to AI-Driven T cell Target Identification and Receptor Engagement	Businesswire
19-Dec-2023	Premium Audio Brand Master & Dynamic Launch New Era of Smart Audio Products Powered by Neurotechnology Leader Neurable Inc.	Businesswire
19-Dec-2023	Revvity to Present at J.P. Morgan Healthcare Conference	Businesswire
19-Dec-2023	Cytomos unveils patented AuraCyt™ brand and launches new website for its transformative cell analysis technology	Cytomos
19-Dec-2023	Almirall to participate in the 42nd Annual J.P. Morgan Healthcare Conference	Almirall S.A. (BME: ALM),
19-Dec-2023	Otsuka and Ionis enter into licensing agreement covering Europe for hereditary angioedema	Otsuka Pharmaceutical Europe Ltd
19-Dec-2023	Biosynth to Offer Complex Chemistry Solutions at Greater Scales Following Acquisition of VIO Chemicals	Biosynth
19-Dec-2023	Philip Morris International Announces Senior Global Communications Leadership Changes	Businesswire
19-Dec-2023	New hot-flush treatment VEOZA▼™ (fezolinetant): first-in-class non-hormonal medicine for moderate to severe vasomotor symptoms associated with menopause licensed in Great Britain	Astellas Pharma Inc
19-Dec-2023	Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction	Achilles Therapeutics
19-Dec-2023	Shionogi announces agreement with SOBI on Fetcroja®▼ (cefiderocol) to expand access for patients with infections due to aerobic Gram-negative organisms in adults with limited treatment options.	Shionogi B.V.
19-Dec-2023	Santhera’s AGAMREE (Vamorolone) Approved in the European Union for the Treatment of Duchenne Muscular Dystrophy	Santhera Pharmaceuticals
19-Dec-2023	Recipharm Harmonises its Global Quality Operations with Veeva Vault Quality	Veeva Systems
19-Dec-2023	MAIA Biotechnology Announces Dose Selection in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer	Businesswire
19-Dec-2023	Aldeyra Therapeutics Announces Statistically and Clinically Significant Improvement from Baseline in Phase 2 Clinical Trial of ADX‑629 in Patients with Atopic Dermatitis	Businesswire